Aegera Therapeutics, Inc.
Biotech company adds six patents to apoptosis patent estate
Published in Medicine and Law Weekly, October 29th, 2004
Aegera now has a total of 19 issued U.S. patents and one issued European patent covering five of the eight known IAPs. Aegera's IAP patent portfolio is based on the discoveries of two of their scientific founders, Robert Korneluk and Alex MacKenzie. With a priority date going back to August of 1995, Aegera has firmly established themselves as a key player in the development of apoptosis-related therapeutics.
The mechanisms by which cells execute apoptosis, or natural cell death, involve the irreversible activation of key...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- BioProgress Technology Limited
High Court judgment announced in patent entitlement case - Hana Biosciences, Inc.
Biopharmaceutical company changes name, reincorporates in Delaware - Hollis-Eden Pharmaceuticals, Inc.
Neumune improves survival in non-human primates after radiation exposure - Amedica Corporation
Patent issued covering novel spinal grafts - American Legacy Foundation
Government, public health, tobacco company officials discuss youth smoking - BTG
Agreement signed with the University of Illinois to develop sleep therapy - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
